Commission Implementing Decision (EU) 2025/2344 of 19 November 2025 repealing Implementing Decision (EU) 2024/2930 postponing the expiry date of the approval of dazomet for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
073/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Decision (EU) 2025/2344 of 19 November 2025 repealing Implementing Decision (EU) 2024/2930 postponing the expiry date of the approval of dazomet for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Durchführungsbeschluss (EU) 2025/2344 der Kommission vom 19. November 2025 zur Aufhebung des Durchführungsbeschlusses (EU) 2024/2930 zur Verschiebung des Ablaufdatums der Genehmigung für Dazomet zur Verwendung in Biozidprodukten der Produktart 8 gemäß der Verordnung (EU) Nr. 528/2012 des Europäischen Parlaments und des Rates
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.